Chronic methanol exposure induces cognitive impairment and Alzheimer's-like pathology in rhesus monkeys

Hongwei Li1, Changhua Shi1, Keya Li1

  • 1National Human Diseases Animal Model Resource Center, NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Engineering Research Center for Experimental Animal Models of Human Critical Diseases, National Center of Technology Innovation for Animal Model, Chinese Academy of Medical Sciences (CAMS), Peking Union Medical College (PUMC), Beijing, China.

Abstract

Insights

Chronic methanol exposure in monkeys caused cognitive decline and Alzheimer

Area of Science:

  • Neuroscience and Toxicology
  • Primate Models for Neurodegenerative Diseases

Background:

  • Lack of effective animal models for sporadic Alzheimer's disease (AD) hinders therapeutic development.
  • Endogenous formaldehyde, a byproduct of methanol metabolism, is a neurotoxic agent linked to cognitive decline.

Purpose of the Study:

  • To investigate if chronic, low-dose methanol exposure can induce AD-like pathology and cognitive deficits in rhesus monkeys.
  • To establish a nonhuman primate model for sporadic AD using an environmental-metabolic insult.

Main Methods:

  • Adult rhesus monkeys were exposed to low-concentration methanol for nine months.
  • Behavioral tests assessed cognition, locomotion, sleep, and vision.
  • Postmortem analyses included histopathology, immunohistochemistry, immunofluorescence, and Western blot to evaluate neuropathology and molecular markers of AD and cellular stress.

Main Results:

  • Methanol exposure resulted in progressive cognitive and memory impairment, with no significant motor or visual deficits.
  • Neuropathology showed brain atrophy, neuronal loss, synaptic damage, microglial activation, and mitochondrial disorganization.
  • Exposed animals displayed hallmark AD-like changes: increased amyloid-β deposition, tau hyperphosphorylation, and TDP-43 dysregulation, linked to elevated formaldehyde, mitochondrial fission, autophagy, and apoptosis.

Conclusions:

  • Chronic low-dose methanol exposure in rhesus monkeys effectively replicates cognitive deficits and neuropathological features of sporadic Alzheimer's disease.
  • This formaldehyde-toxicity-driven model offers a reproducible and translationally relevant nonhuman primate model for AD research and therapeutic evaluation.